4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-23-010557
Options or other derivatives
- Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Regnante Keith Chief Financial Officer | 2023-02-16 | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/doc4.xml…